<DOC>
	<DOCNO>NCT01733745</DOCNO>
	<brief_summary>The purpose study assess efficacy SYSTANE® family product ( SYSTANE® Lid Wipes , SYSTANE® BALANCE Lubricant Eye Drops , SYSTANE® Vitamins ) meibomian gland functionality subject lipid deficiency relate evaporative dry eye compare standard care warm compress .</brief_summary>
	<brief_title>SYSTANE® Family - Meibomian Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Must clinical diagnosis lipid deficient Evaporative Dry Eye ; Meibomian Gland Functionality Not 6 gland yield liquid secretion ; Must willing discontinue use Meibomian Gland ; Dysfunction management prior receive study test article Visit 1 , end study period ; Must best correct visual acuity 20/40 Snellen good eye ; Must able follow instruction willing able attend require study visit ; Must read , sign , date Ethics Committee review approve informed consent form ; Other protocoldefined inclusion criterion may apply . History evidence ocular intraocular surgery serious ocular trauma either eye within past 6 month ; Current punctal occlusion type ( e.g. , collagen plug , silicone plug ) ; History intolerance hypersensitivity component study medication ; History evidence epithelial herpes simplex keratitis ( dendritic keratitis ) ; vaccinia ; active recent varicella viral disease cornea and/or conjunctiva ; chronic bacterial disease cornea and/or conjunctiva and/or eyelid ; mycobacterial infection eye ; and/or fungal disease eye ; Pregnant lactating time enrollment ; Not willing take adequate precaution become pregnant study ; Use concomitant topical ocular medication study period ; Use systemic medication may contribute dry eye unless stable dose regimen minimum 30 day prior Visit 1 ; Ocular condition may preclude safe administration either drop investigation ; Unwilling discontinue contact lens wear study period least 1 week prior Visit 1 ; Participation investigational drug device study within 30 day enter study ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>dry eye</keyword>
	<keyword>lipid deficiency</keyword>
	<keyword>meibomian gland</keyword>
</DOC>